Neoadjuvant Nivolumab + Relatlimab (Opdualag) Versus Nivolumab for Resectable High-Risk Basal Cell Carcinoma (NCT06624475)
Randomized Phase II Trial Neoadjuvant Nivolumab + Relatlimab (Opdualag) Versus Nivolumab for Resectable High-Risk Basal Cell Carcinoma
🩺 Plain-English Summary (8th-Grade Level)
This is a Phase 2 clinical trial with a 2:1 randomization comparing neoadjuvant Nivolumab + Relatlimab (Opdualag) vs neoadjuvant Nivolumab in patients with resectable high risk basal cell carcinoma (HR BCC)
Who can join: Review the eligibility criteria below.
Location: University of California, Irvine — Irvine, California
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (3 Sites)
- University of California, Irvine — Irvine, California
- University of California, San Diego Moores Cancer Center — La Jolla, California
- University of California, San Francisco — San Francisco, California
📞 Contact the Study Coordinator
Phone: (858) 822-5354
Email: CancerCTO@health.ucsd.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Basal Cell Carcinoma
- Placebo Microneedles in Healthy Volunteers (Part I) and Efficacy/Safety of Doxorubicin Microneedles in Basal Cell Cancer Subjects (Part II) — West Palm Beach, Florida
- A Study of Observation and Follow-up in People With Basal Cell Carcinoma — New York, New York
- Optical Coherence Tomography Guided Laser Treatment of Basal Cell Carcinoma — Irvine, California
- A Study on Radiation Therapy Guided by the Reflectance Confocal Microscopy (RCM)/Optical Coherence Tomography (OCT) Device in People With Basal Cell Carcinoma — Basking Ridge, New Jersey
- Alteration of the Immune Microenvironment in Basal Cell Carcinoma Following Photodynamic Therapy — Cleveland, Ohio
- Basal Cell Carcinoma Chemoprevention Trial — Providence, Rhode Island
Explore by condition: All Basal Cell Carcinoma clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.